Immunohistochemistry (IHC)
Antibody staining that types a tumour and identifies treatment targets.
Also known as: IHC, immunostaining, ER PR HER2, tumour markers tissue
Price on request
This one is done at the centre — it cannot be collected at home. Find your nearest branch.
- Turnaround
- 7–10 working days
- Preparation
- No fasting needed. Eat and drink normally.
- Sample
- In-clinic procedure
Questions about this test? Message us
About this test
Performed on tissue already taken, using a panel of over sixty antibodies on automated platforms. It classifies tumours that look similar under ordinary staining, identifies the primary site of a metastasis, and reports the receptors — ER, PR and HER2 in breast cancer — that determine which treatments will work.
What it measures
- Marker expression across the selected antibody panel
- Hormone receptor and HER2 status where applicable
- Lymphoma phenotyping
A note on results. A single test is one part of a clinical picture, not a diagnosis. Discuss your report with a qualified doctor, who will read it alongside your history and examination.
Related to
- Cancer screening
Often ordered with this
AFP (Alpha-Fetoprotein)
A liver and germ-cell tumour marker, also used in antenatal screening.
- 24–48 hours
- No fasting
- Home collection
BCR-ABL
Diagnoses chronic myeloid leukaemia and measures response to treatment.
- 10–14 working days
- No fasting
- Home collection
Beta-2 Microglobulin
Used to stage myeloma and lymphoma, and to assess kidney handling.
- 3–5 working days
- No fasting
- Home collection